000 | 00912 a2200289 4500 | ||
---|---|---|---|
005 | 20250516040752.0 | ||
264 | 0 | _c20110817 | |
008 | 201108s 0 0 cze d | ||
022 | _a0042-773X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHaluzĂk, M | |
245 | 0 | 0 |
_a[Treatment of type 2 diabetes mellitus with GLP-1 agonists]. _h[electronic resource] |
260 |
_bVnitrni lekarstvi _cApr 2011 |
||
300 |
_a411-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
650 | 0 | 4 | _aExenatide |
650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xagonists |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIncretins _xtherapeutic use |
650 | 0 | 4 | _aLiraglutide |
650 | 0 | 4 |
_aPeptides _xtherapeutic use |
650 | 0 | 4 |
_aVenoms _xtherapeutic use |
700 | 1 | _aUrbanová, M | |
700 | 1 | _aTrachta, P | |
773 | 0 |
_tVnitrni lekarstvi _gvol. 57 _gno. 4 _gp. 411-5 |
|
999 |
_c20872903 _d20872903 |